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Abstract
Purpose Primary central nervous system lymphoma (PCNSL)
is a rare disease. The index report describes a patient with
intraocular lymphoma secondary to recurrent PCNSL and
corresponding retinal findings on spectral domain optical co-
herence tomography (SD-OCT).
Methods Case report.
Results OCT changes were documented and correlated with
the clinical course of intraocular lymphoma progression in the
index patient. The OCTchanges, manifested as hyperreflective
material accumulation in the intraretinal and subretinal pigment
epithelial spaces, were caused by lymphomatous infiltration.
Conclusion SD-OCT can be useful in diagnosing and mon-
itoring the progression or regression of intraocular lympho-
ma with retinal involvement.
Keywords Spectral Domain Optical Coherence
Tomography . SD-OCT. Intraocular lymphoma .
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Introduction
Primary central nervous system lymphoma (PCNSL) is a
rare disease, representing 4 % to 6 % of all primary brain
tumors and 1 % to 2 % of all extranodal lymphomas [1].
Intraocular lymphoma is a subset of PCNSL that usually
involves the retina, the vitreous, or the optic nerve. It is a
high-grade, malignant tumor, usually of large B cell histol-
ogy with the following features: high nuclear to cytoplasm
ratios, coarse chromatin, irregular nuclear contours, promi-
nent nucleoli or chromocenters, and occasional presence of
mitotic figures [2]. It has been reported that up to 25 % of
patients with PCNSL will have vitreoretinal and choroidal
involvement [1]. We describe a case of a patient with intraoc-
ular lymphoma secondary to recurrent PCNSL with cor-
responding findings on spectral domain optical coherence
tomography (Spectralis HRA+OCT®, Heidelberg, Vista,
CA). Following initially successful chemotherapy, relapse
was presented as rapid, dramatic visual loss. While fundus
examination, fundus photography, and fluorescein angiography
showed minimal changes or abnormalities, spectral domain
optical coherence tomography (SD-OCT) showed substantial
diffuse changes in the fovea, which represented intraretinal
and subretinal pigment epithelium (RPE) lymphomatous
infiltration.
Case report
A 72-year-old man presented to the Wilmer Eye Institute in
November 2010, complaining of blurry vision in the left eye
of 6-week duration. He was diagnosed with PCNSL in
2008, underwent systemic methotrexate and rituximab in
2009, and by early 2010, his disease was in remission. At
presentation, the visual acuity with correction in his right
eye was 20/25; examination in the right eye was unremark-
able. The visual acuity with correction in his left eye was 20/
100. Slit-lamp examination in the left eye was remarkable
for mutton fat keratic precipitates, 1+ cells and flare in the
anterior chamber, and sheets of cells in the vitreous. B-scan
ultrasonography of the left eye revealed vitreous opacity; the
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optic nerve appeared normal. A diagnostic vitrectomy of the
left eye confirmed the diagnosis of diffuse, large B cell,
intraocular lymphoma, which was cytologically consistent
with his previous PCNSL.
Intravenous methotrexate and rituximab were initiated.
The patient also received one intravitreal injection of meth-
otrexate in his left eye. During his subsequent follow-up
visits in December 2010, February 2011, and April 2011,
the patient’s visual acuity with correction in the left eye
improved to 20/20 and the vitreous in the left eye remained
clear. However, intravenous methotrexate was discontinued
in April due to renal function abnormality, and the patient
was maintained on an every 2-week rituximab regimen.
The patient presented again in May 2011 and complained
of decreased vision in the left eye of 2-week duration. The
visual acuity with correction in the right eye was 20/20;
examination of the right eye was unremarkable. The visual
acuity with correction in the left eye was 20/250, decreased
from 20/20 one month earlier. The left eye examination was
remarkable for presence of keratic precipitates, 1+ cells and
flare in the anterior chamber, 0.5+ vitreous haze but no
vitreous cells. On fundus photography, there was a new area
of hypopigmentation (Fig. 1b) that was not present 1 month
earlier (Fig. 1a). On angiography, there was no leakage in
the fovea in the late frames (Fig. 1c).
OCT of the left eye fovea revealed the presence of a
moderately hyperreflective intraretinal material that was
absent 1 month earlier (Fig. 2a). The intraretinal material
appeared to be masking the photoreceptor, inner segment/
outer segment (IS/OS), and the external limiting membrane
(ELM) layers (arrows). The outer nuclear layer and outer
plexiform layer were involved as well (circled), but the inner
retinal layers were spared (Fig. 2b).
The frequency of prednisolone acetate was increased to six
times a day to control the iridocyclitis in the left eye. Over the
course of the next 2 months, signs of inflammation in the left
eye subsided, and the visual acuity with correction in the left
eye improved to 20/40. At that time, OCT from the left eye
demonstrated, in addition to the previously noted intraretinal
hyperreflective material, newly developed pigment epithelial
elevations accompanied by diffuse hyperreflective sub-RPE
deposits and an intact Bruch’s membrane (Fig. 2c).
Discussion
To our knowledge, the index case report is the first to
document longitudinal OCT changes, which are temporally
correlated with a decrease of visual acuity, in a patient with a
history of intraocular lymphoma and retinal involvements.
Despite the lack of histopathological evidence from the
retina, we believe, given the clinical findings, that the hyper-
reflective materials shown on OCT most probably represent
lymphomatous infiltrations for several reasons.
Fig. 1 Fundus photography
and fluorescein angiography
(FA) of the left eye. a Color
fundus photograph taken in
April 2011; visual acuity (VA)
was 20/20 and OCT was
normal. b Color fundus
photograph taken in May 2011;
VA was 20/250 with abnormal
findings in OCT images. The
photograph showed a new
hypopigmented lesion in the
fovea (arrow) that was not seen
the month prior. c Late frame of
the FA done in May 2011
showed no leakage in the fovea.
The white circular lesions seen
between the optic nerve head
and fovea in a and b are
imaging artifacts
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First, prior case reports have shown that infiltration of
lymphoma cells into the retina could cause a whitening of
the retina [3]. Such reports could explain the appearance of
the new hypopigmented lesion in the left eye fovea
(Fig. 1b), which coincided with the decrease in our patient’s
visual acuity and appearance of new OCT findings.
Second, Chan and colleagues used a murine model to
show that lymphoma cells in the vitreous could migrate
through the retina and gather between the neural retina and
the RPE [4]. Such collection of cells could explain the
presence of the hyperreflective material that masked the
ELM and IS/OS junction in the OCT of our index patient
(Fig. 2b). We believe that the accumulation of such hyper-
reflective material, which most likely represented lympho-
matous infiltration, resulted in disruption of the IS/OS
junction and contributed to the visual decline in our patient.
Third, several histopathological studies of autopsied eyes
from patients with primary intraocular lymphoma have
revealed the presence of malignant cells between the RPE
and Bruch’s membrane [5–7]. The malignant cells are most
likely represented as the hyperreflective sub-RPE deposits
seen in our OCT, which may have contributed to the newly
detected pigment epithelial elevations (Fig. 2c). Furthermore,
the migration of malignant cells from the vitreous to the retina,
as demonstrated by Chan et al., may explain the appearance of
the hyperreflective material in the outer neuroretinal layers
before accumulation in the sub-RPE space. However, it does
not explain the apparent sparing of the inner retinal layers.
Although other authors have reported OCT findings that
they attributed to lymphomatous infiltration [8–12], our
index case is the first to document changes in SD-OCT that
have correlated with a clinical course of intraocular lympho-
ma progression. Since we were able to compare subsequent
OCT findings with the baseline OCT scan, we believe that
the intraretinal and sub-RPE hyperreflective materials were
indeed lymphomatous infiltration.
Conclusion
Intraocular lymphoma may cause visual loss through diffuse
retinal infiltration. Spectral domain OCT may provide the
necessary resolution to visualize such lymphomatous infil-
tration, and it can be useful in diagnosing and monitoring
the progression or regression of intraocular lymphoma with
retinal involvement.
Fig. 2 OCT of the left eye. a April 2011: normal appearing retinal
layers accompanying a visual acuity (VA) of 20/20. There was a layer
of hyperreflective material superficial to the nerve fiber layer and nasal
to the fovea. It most likely represented epiretinal membrane and
remained unchanged throughout the visits (arrowheads). b May
2011: The patient’s VA decreased to 20/250 with an OCT showing
the presence of a moderately hyperreflective material within the outer
retina (arrows). Of note, there was increased irregularity in the RPE;
the IS/OS junction and the ELM could no longer be visualized. The
outer nuclear layer and outer plexiform layer appeared to be involved
as well (encircled). c July 2011: In addition to the intraretinal hyper-
reflective material noted 2 months earlier, the OCT showed newly
developed pigment epithelial elevations accompanied by heteroge-
neous, hyperreflective sub-RPE deposits (arrows). We used Spectralis
HRA+OCT™ with the Automated TruTrak™ functionality, which
allowed automated real-time, point-to-point registration of images
taken at different time points. Therefore, the three scans presented in
this figure were referenced and represented the same section of the
retina
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